Alnaggar, Mohammed
Xu, Yan
Li, Jingxia
He, Junyi
Chen, Jibing
Li, Man
Wu, Qingling
Lin, Li
Liang, Yingqing
Wang, Xiaohua
Li, Jiawei
Hu, Yi
Chen, Yan
Xu, Kecheng
Wu, Yangzhe
Yin, Zhinan
Article History
Received: 3 October 2018
Accepted: 9 January 2019
First Online: 8 February 2019
Ethics approval and consent to participate
: The study protocol received ethical approval from the Regional Ethics Committee of Guangzhou Fuda Cancer Hospital, China. Written informed consent was obtained from participant in accordance with the Declaration of Helsinki, andExternalRef removedID: NCT02425735.
: Not applicable.
: The IND for allogenic γδ T cell application in clinical therapy is filling in both PR China and USA.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.